RT Journal Article
SR Electronic
T1 Correspondence on ‘Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case–control study’ by Potere <em>et al</em>
JF Annals of the Rheumatic Diseases
JO Ann Rheum Dis
FD BMJ Publishing Group Ltd and European League Against Rheumatism
SP e194
OP e194
DO 10.1136/annrheumdis-2020-218693
VO 81
IS 10
A1 Leo Buckley
YR 2022
UL http://ard.bmj.com/content/81/10/e194.abstract
AB